Impact of excess weight and estrogen receptor gene polymorphisms on clinical course of homozygous β thalassemia

Hematology

Volumn 10, Issue 5, 2005, Pages 407-411

  Ferrara, M ^a   Matarese, S M R ^a   Borrelli, B ^a   Francese, M ^b   Perrotta, A ^a   Simeone, G ^a   Greco, N ^a   Iarussi, D ^a   Capozzi, L ^a   Esposito, L ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Naples Second University ^*

Author keywords

BMI; ER gene polymorphism; Homozygous thalassemia; Lipidic pattern

Indexed keywords

ESTROGEN RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; ERYTHROCYTE TRANSFUSION; FEMALE; GENE INTERACTION; GENOTYPE; HUMAN; IRON CHELATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THALASSEMIA MAJOR; WEIGHT GAIN;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD PRESSURE; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; FEMALE; HOMOZYGOTE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; OVERWEIGHT; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREDICTIVE VALUE OF TESTS; RECEPTORS, ESTROGEN; RISK FACTORS; TRIGLYCERIDES;

EID: 29144452217     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330500141788     Document Type: Article

References (10)

1. Duncan AC, Petrie JR, Brosnan MJ, Devlin AM, Bass RA, Charnock-Jones DS, Connell JM, Dominiczak AF, Lumsden MA. Is estradiol cardioprotection a nitric oxide-mediated effect? Hum Reprod 2002;17:1918-1924.
2. Willing M, Sowers M, Aron D, Clark MK, Burns T, Bunten C, Crutchfield M, D'Agostino D, Jannausch M. Bone mineral density and its change in white women: Estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 1998;13:695-705.
3. Speer G, Cseh K, Winkler G, Vargha P, Braun E, Takacs I, Lakatos P. Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and android type obesity. Eur J Endocrinol 2001;144:384-389.
4. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children. Arch Dis Child 1966;41:613-635.
5. Menghetti E, Virdis R, Strambi M, Patriarca V, Riccioni MA, Fossali E, Spagnolo A. Blood pressure in childhood and adolescence: The Italian normal standards. 'Study Group on Hypertension' of the 'Italian Society of Pediatrics'. J Hypertens 1999;17:1363-1372.
6. Suarez F, Rossignol C, Garabedian M. Interactive effect of estradiol and vitamin D receptor gene polymorphisms as a possible determinant of growth in male and female infants. J Clin Endocrinol Metab 1998;83:3563-3568.
7. Livrea MA, Tesoriere L, Maggio A, D'Arpa D, Pintaudi AM, Pedone E. Oxidative modification of low-density lipoprotein and atherogenetic risk in beta-malassemia. Blood 1998;92:3936-3942.
8. Kikuchi T, Hashimoto N, Kawasaki T, Uchiyama M. Association of serum low-density lipoprotein metabolism with oestrogen receptor gene polymorphisms in healthy children. Acta Pediatrica 2000;89:42-45.
9. Matsubara Y, Murata M, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vase Biol 1997;17:3006-3012.
10. Eckel RH, Krauss RM. American Heart Association call to action: Obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998;97:2099-2100.